BSE Live
Jan 23, 16:01Prev. Close
458.10
Open Price
458.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:48Prev. Close
458.00
Open Price
460.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
440.25 (137)
| Key Financial Ratios of Thyrocare Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 17.13 | 13.42 | 12.16 | 33.30 | 21.41 | |
| Diluted EPS (Rs.) | 17.08 | 13.40 | 12.14 | 33.25 | 21.37 | |
| Cash EPS (Rs.) | 27.83 | 21.93 | 19.25 | 39.73 | 27.14 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 103.18 | 99.65 | 101.12 | 99.54 | 80.82 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 103.18 | 99.65 | 101.12 | 99.54 | 80.82 | |
| Revenue from Operations/Share (Rs.) | 129.71 | 108.00 | 99.50 | 111.32 | 93.55 | |
| PBDIT/Share (Rs.) | 38.72 | 27.72 | 24.27 | 49.93 | 34.74 | |
| PBIT/Share (Rs.) | 28.29 | 18.85 | 16.96 | 43.53 | 29.02 | |
| PBT/Share (Rs.) | 27.72 | 18.05 | 16.51 | 43.08 | 28.85 | |
| Net Profit/Share (Rs.) | 17.40 | 13.05 | 11.94 | 33.33 | 21.41 | |
| NP After MI And SOA / Share (Rs.) | 17.27 | 13.36 | 12.16 | 33.30 | 21.40 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 29.85 | 25.66 | 24.39 | 44.85 | 37.13 | |
| PBIT Margin (%) | 21.81 | 17.44 | 17.04 | 39.10 | 31.01 | |
| PBT Margin (%) | 21.36 | 16.71 | 16.59 | 38.70 | 30.83 | |
| Net Profit Margin (%) | 13.41 | 12.08 | 11.99 | 29.94 | 22.89 | |
| NP After MI And SOA Margin (%) | 13.31 | 12.37 | 12.22 | 29.91 | 22.87 | |
| Return on Networth/Equity (%) | 16.73 | 13.43 | 12.04 | 33.45 | 26.48 | |
| Return on Capital Employed (%) | 26.26 | 18.03 | 16.15 | 42.39 | 34.03 | |
| Return on Assets (%) | 13.20 | 10.98 | 10.17 | 28.98 | 20.73 | |
| Total Debt/Equity (X) | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 1.03 | 0.90 | 0.80 | 0.98 | 90.62 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.77 | 3.08 | 3.54 | 4.19 | 2.50 | |
| Quick Ratio (X) | 2.39 | 2.55 | 3.18 | 3.80 | 2.26 | |
| Inventory Turnover Ratio (X) | 14.62 | 4.38 | 5.82 | 6.80 | 21.17 | |
| Dividend Payout Ratio (NP) (%) | 104.15 | 134.63 | 123.29 | 45.02 | 46.69 | |
| Dividend Payout Ratio (CP) (%) | 64.93 | 80.89 | 76.98 | 37.76 | 36.84 | |
| Earnings Retention Ratio (%) | -4.15 | -34.63 | -23.29 | 54.98 | 53.31 | |
| Cash Earnings Retention Ratio (%) | 35.07 | 19.11 | 23.02 | 62.24 | 63.16 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 67.28 | 34.95 | 54.67 | 111.45 | 176.33 | |
| Interest Coverage Ratios (Post Tax) (%) | 67.28 | 34.95 | 54.67 | 111.45 | 176.33 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3,550.20 | 3,118.27 | 2,246.85 | 4,079.23 | 4,758.17 | |
| EV/Net Operating Revenue (X) | 5.17 | 5.45 | 4.27 | 6.93 | 9.62 | |
| EV/EBITDA (X) | 17.30 | 21.24 | 17.49 | 15.44 | 25.90 | |
| MarketCap/Net Operating Revenue (X) | 5.24 | 5.48 | 4.32 | 6.95 | 9.65 | |
| Retention Ratios (%) | -4.15 | -34.63 | -23.29 | 54.97 | 53.30 | |
| Price/BV (X) | 6.59 | 5.95 | 4.26 | 7.77 | 11.17 | |
| Price/Net Operating Revenue | 5.24 | 5.48 | 4.32 | 6.95 | 9.65 | |
| Earnings Yield | 0.03 | 0.02 | 0.03 | 0.04 | 0.02 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss